BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1803620)

  • 1. The factor VIII bypassing activity of prothrombin complex concentrates: the roles of factor VIIa and of endothelial cell tissue factor.
    Teitel JM
    Thromb Haemost; 1991 Nov; 66(5):559-64. PubMed ID: 1803620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endothelial cell and the factor VIII bypassing activity of prothrombin complex concentrate.
    Teitel JM; Ni HY; Freedman JJ; Garvey MB
    Thromb Haemost; 1988 Oct; 60(2):226-9. PubMed ID: 3146140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.
    Sultan Y; Loyer F
    J Lab Clin Med; 1993 Mar; 121(3):444-52. PubMed ID: 8445292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa.
    Speidel CM; Thornton JD; Meng YY; Eisenberg PR; Edgington TS; Abendschein DR
    Coron Artery Dis; 1996 Jan; 7(1):57-62. PubMed ID: 8773434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contribution to the mechanism of the "factor VIII bypassing activity" (FEIBA)-reaction].
    Sander W; Wilms K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):581-7. PubMed ID: 1714863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.
    Kirchhofer D; Tschopp TB; Hadváry P; Baumgartner HR
    J Clin Invest; 1994 May; 93(5):2073-83. PubMed ID: 8182139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
    Almus FE; Rao LV; Rapaport SI
    Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue factor expression in endothelial cell/monocyte cocultures stimulated by lipopolysaccharide and/or aggregated IgG. Mechanisms of cell:cell communication.
    Wharram BL; Fitting K; Kunkel SL; Remick DG; Merritt SE; Wiggins RC
    J Immunol; 1991 Mar; 146(5):1437-45. PubMed ID: 1993838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin enhances monocyte secretion of tumor necrosis factor and interleukin-1 beta by two distinct mechanisms.
    Hoffman M; Cooper ST
    Blood Cells Mol Dis; 1995; 21(2):156-67. PubMed ID: 8846045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa.
    Reuning U; Preissner KT; Müller-Berghaus G
    Thromb Haemost; 1993 Feb; 69(2):197-204. PubMed ID: 8456434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intradermal tumor necrosis factor-alpha-induced inflammation on coagulation factors in dermal vessel endothelium. An in vivo study of human skin biopsies.
    Speiser W; Kapiotis S; Kopp CW; Simonitsch I; Jilma B; Jansen B; Exner M; Chott A
    Thromb Haemost; 2001 Feb; 85(2):362-7. PubMed ID: 11246561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells.
    Warn-Cramer BJ; Almus FE; Rapaport SI
    Thromb Haemost; 1989 Feb; 61(1):101-5. PubMed ID: 2665164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolysis of blood coagulation factor VIII by the factor VIIa-tissue factor complex: generation of an inactive factor VIII cofactor.
    Warren DL; Morrissey JH; Neuenschwander PF
    Biochemistry; 1999 May; 38(20):6529-36. PubMed ID: 10350471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pathway of coagulation on endothelial cells.
    Nawroth PP; Stern DM
    J Cell Biochem; 1985; 28(4):253-64. PubMed ID: 3877062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation.
    Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Roberts HR
    Thromb Haemost; 1998 Oct; 80(4):578-84. PubMed ID: 9798973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of tissue factor on monocytes by adhesion to endothelial cells.
    Lo SK; Cheung A; Zheng Q; Silverstein RL
    J Immunol; 1995 May; 154(9):4768-77. PubMed ID: 7536780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of plasma clotting factors with vascular endothelial cells in hemostasis and thrombosis with special reference to endothelial cell tissue factor.
    Narahara N; Uchiyama T; Andoh K; Tanaka H; Kobayashi N
    Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1330-6. PubMed ID: 2629458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of human factor VII activation.
    Butenas S; Mann KG
    Biochemistry; 1996 Feb; 35(6):1904-10. PubMed ID: 8639673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.